RAMUCIRUMAB for Gastric cancer stage iv: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 178 adverse event reports in the FDA FAERS database where RAMUCIRUMAB was used for Gastric cancer stage iv.
Most Reported Side Effects for RAMUCIRUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 743 | 13.9% | 343 | 243 |
| Death | 492 | 9.2% | 492 | 51 |
| Interstitial lung disease | 269 | 5.0% | 55 | 131 |
| Febrile neutropenia | 229 | 4.3% | 70 | 148 |
| Neutropenia | 229 | 4.3% | 45 | 58 |
| Decreased appetite | 187 | 3.5% | 37 | 96 |
| Diarrhoea | 186 | 3.5% | 34 | 92 |
| Hypertension | 175 | 3.3% | 31 | 58 |
| Pyrexia | 161 | 3.0% | 27 | 107 |
| Nausea | 160 | 3.0% | 39 | 69 |
| Fatigue | 159 | 3.0% | 28 | 55 |
| Disease progression | 153 | 2.9% | 39 | 31 |
| Ascites | 152 | 2.8% | 40 | 74 |
| Neutrophil count decreased | 150 | 2.8% | 30 | 72 |
| Off label use | 148 | 2.8% | 30 | 49 |
Other Indications for RAMUCIRUMAB
Gastric cancer (1,257)
Product used for unknown indication (780)
Non-small cell lung cancer (405)
Lung neoplasm malignant (304)
Adenocarcinoma gastric (264)
Colon cancer (222)
Oesophageal adenocarcinoma (158)
Hepatocellular carcinoma (156)
Metastatic gastric cancer (156)
Gastric cancer recurrent (128)
Other Drugs Used for Gastric cancer stage iv
OXALIPLATIN (227)
PACLITAXEL (113)
GIMERACIL\OTERACIL\TEGAFUR (107)
FLUOROURACIL (93)
PEMBROLIZUMAB (92)
CISPLATIN (84)
CAPECITABINE (78)
TRASTUZUMAB (65)
NIVOLUMAB (54)
LEUCOVORIN (40)